MedTrace Logo

A Clinical Study to Evaluate the Efficacy of a Nutritional Supplement to Improve Carotenoid Content as Measured by a Non-invasive Hyperspectral Absorption Device

NCT07380438 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2026-02-02

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate a nutritional supplement in an otherwise healthy adult population. The main questions it aims to answer are:

* Do antioxidant carotenoid levels increase in after supplementation as measured by a non-invasive device?
* Do wellness factors correlate with supplementation?

Researchers will compare the nutritional supplement arm to a placebo group to assess its effects.

Participants will take either the nutritional supplement or placebo once daily for 8 weeks. Participants will be scanned by a non-invasive hyperspectral absorption device to obtain a skin carotenoid score. Participants will also have facial images taken, dermal spectrophotometry measurements of their face, and complete self-assessment questionnaires.

Conditions

  • Nutrition Assessment

Interventions

DIETARY_SUPPLEMENT

LifePak Optimum nutritional supplement

Ca(mg) Vit C(mg) Mg(mg) Se(㎍) Cr(㎍) Vit E(mg a-TE) Mo(㎍) Pantothenic acid(mg) Vit B12(㎍) Niacin(mgNE) Zn(mg) Vit B6(mg) Biotin(㎍) Vit D(㎍) Vit B1(mg) Vit B2(mg) Cu(mg) Mn(mg) Vit K(㎍) Folic acid(㎍)\_Folic acid Iodine(㎍) Beta-carotene(mg) Lycopene(mg) Lutein(mg)

DIETARY_SUPPLEMENT

Placebo supplement

Placebo supplement

Sponsors & Collaborators

  • Yonsei University

    collaborator OTHER

  • Pharmanex

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-10-20
Primary Completion
2025-11-20
Completion
2026-01-08

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07380438 on ClinicalTrials.gov